Fig. 5From: Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysisDPP-4 inhibitors/GLP-1 agonists VS insulin glargine/placebo in QoLBack to article page